Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe ...

Seed packets look simple, but they often hide key instructions and use confusing jargon. Especially for new gardeners who ...

Chief Commercial Officer David Lin reported, “ZUSDURI generated $1.8 million in net product revenue in Q3, and $14 million in Q4, bringing full year 2025 revenue to $15.8 million,” and detailed ...

CICO is broken. But there’s a fix.

Only 36 convertible GTX examples got the 426 Hemi engine for 1968, and this green and white example is the proverbial Schroedinger’s cat case ...

A growing body of research suggests engagement in the arts supports psychological well-being, helping young people manage ...

Patients with oHCM experience significant variation in cardiovascular events, health care resource use, and costs across age, sex, race, and US region.

In November, I halted a rehearsal and walked out. My choir was preparing for our winter concert at Chicago’s Symphony Center.

A federal rule change could lower disability compensation for millions of veterans, says the Veterans of Foreign Wars.

ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries -- Dublin-based subsidiary to support ImmunityBio's distribution and ...